Class II · Moderate risk
Herpes Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
FDA drug recalls in 2020
Every FDA drug recall initiated in 2020, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
930 recalls, newest first.
Class II · Moderate risk
Herpes-G
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Hernia Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Hair Back Lotion
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Hair Back Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fungo Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fungo Lotion
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fungo Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fungo Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Flare Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Fire Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Edema Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dragon Pain Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Detoxin-S
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Detoxin Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
DeTensin Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermatoxin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermamycin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
De-Fibroidin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Cellulite Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Blood Clot Purger
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Bleeding Stop
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Asthma Chest Rub
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Asma Stopper
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Age Stop Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs